We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+19.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$45.9B
AUM Growth
+$5.92B
(+15%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-0.41%
Top 10 Holdings %
Top 10 Hldgs %
24.37%
Holding
916
New
168
Increased
229
Reduced
363
Closed
115
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$338M |
| 2 |
ExxonMobil
XOM
|
+$291M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$271M |
| 4 |
GE Aerospace
GE
|
+$205M |
| 5 |
Emerson Electric
EMR
|
+$157M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$310M |
| 2 |
Sensata Technologies
ST
|
+$251M |
| 3 |
Fortive
FTV
|
+$226M |
| 4 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
+$117M |
| 5 |
Honeywell
HON
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.79% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 12.96% |
| 4 | Financials | 12.38% |
| 5 | Communication Services | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Cintas
CTAS
$80.4B
| $50.3M | 0.11% |
568,812
+215,212
| +61% | +$18.7M |
|
202
Cameco
CCJ
$41.2B
| $49.4M | 0.11% |
3,686,089
-800,000
| -18% | -$8.54M |
|
203
Stem
STEM
$51.8M
| $49M | 0.11% |
+119,662
| New | +$30.2M |
|
204
Moody's
MCO
$83.8B
| $48.8M | 0.11% |
168,254
-12,100
| -7% | -$3.38M |
|
|
ABMD
205
DELISTED
Abiomed Inc
ABMD
| $48.7M | 0.11% |
150,143
+49,830
| +50% | +$13.8M |
|
|
FITB
206
Fifth Third Bancorp
FITB
$52.5B
| $48.7M | 0.11% |
1,765,344
+583,794
| +49% | +$14.7M |
|
207
Regeneron Pharmaceuticals
REGN
$79.4B
| $48.6M | 0.11% |
100,606
-1,130
| -1% | -$610K |
|
208
Hartford Financial Services
HIG
$39.1B
| $48.5M | 0.11% |
989,483
-305,000
| -24% | -$13.2M |
|
209
Northrop Grumman
NOC
$78.7B
| $48.4M | 0.11% |
158,847
+11,604
| +8% | +$3.55M |
|
210
HCA Healthcare
HCA
$88.9B
| $48.3M | 0.11% |
293,900
-1,400
| -0.5% | -$205K |
|
211
XP
XP
$8.92B
| $47.9M | 0.1% |
1,206,205
-226,755
| -16% | -$9.26M |
|
|
TWTR
212
DELISTED
Twitter, Inc.
TWTR
| $47.7M | 0.1% |
881,600
-2,600
| -0.3% | -$124K |
|
213
Idexx Laboratories
IDXX
$46.1B
| $47.4M | 0.1% |
94,889
-309
| -0.3% | -$138K |
|
214
DexCom
DXCM
$31.2B
| $46.8M | 0.1% |
506,500
+77,824
| +18% | +$6.95M |
|
215
Ross Stores
ROST
$81B
| $46.8M | 0.1% |
381,020
-15,000
| -4% | -$1.57M |
|
216
Ingersoll Rand
IR
$35B
| $46M | 0.1% |
1,009,223
+657,420
| +187% | +$27.2M |
|
217
Devon Energy
DVN
$49.3B
| $45.8M | 0.1% |
2,899,134
+2,326,094
| +406% | +$28.8M |
|
218
Baxter International
BAX
$14.3B
| $45.7M | 0.1% |
569,002
+4,750
| +0.8% | +$376K |
|
219
Saic
SAIC
$5.06B
| $45.6M | 0.1% |
481,499
+45,511
| +10% | +$4M |
|
|
B
220
Barrick Mining
B
$68.5B
| $45.6M | 0.1% |
2,000,000
-200,000
| -9% | -$5.07M |
|
221
Exelon
EXC
$46.8B
| $45.4M | 0.1% |
+1,508,832
| New | +$44.5M |
|
222
American Electric Power
AEP
$68.6B
| $45.2M | 0.1% |
542,750
+293,000
| +117% | +$25.4M |
|
223
Novavax
NVAX
$1.25B
| $45M | 0.1% |
403,283
+378,283
| +1,513% | +$40.2M |
|
224
DTE Energy
DTE
$29B
| $44.1M | 0.1% |
426,657
+177,439
| +71% | +$18.7M |
|
225
Celldex Therapeutics
CLDX
$3.14B
| $43.8M | 0.1% |
2,500,000
+450,000
| +22% | +$8.1M |
|
Similar funds
Adage Capital Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Adage Capital Partners held 916 positions worth $45.9B, up 15% from $39.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Adage Capital Partners's Q4 2020 filing shows 168 new, 229 increased, 363 reduced and 115 closed positions. Its largest new stake was Tesla: 1,978,500 shares worth $465M. The largest sale was Royalty Pharma, an estimated $310M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Adage Capital Partners's largest Q4 2020 buy was Tesla: 1,978,500 shares worth $465M.
- Adage Capital Partners added most to ExxonMobil in Q4 2020, an estimated $291M increase.
- Adage Capital Partners's biggest Q4 2020 reduction was Royalty Pharma, cutting an estimated $310M.
- Adage Capital Partners fully exited Sensata Technologies in Q4 2020, selling an estimated $251M.
- Adage Capital Partners's ten largest holdings make up 24% of its $45.9B portfolio in Q4 2020.
- Adage Capital Partners opened 168 new positions and closed 115 in Q4 2020.
- Adage Capital Partners's portfolio value rose 15% quarter-over-quarter to $45.9B.
Based on Adage Capital Partners's 13F filing for Q4 2020, filed 16 Feb 2021.